Rachel Okolicsanyi, a scientist from the Genomics Research Centre at QUT’s Institute of Health and Biomedical Innovation, is manipulating mesenchymal stem cells [MSCs] to produce neural cells which can be used to treat brain damage. By introducing different chemicals to specific proteins found in stem cells, researchers can determine which chemicals facilitate, or prohibit, their potential to differentiate into neural cells. This advancement in the understanding of how stem cells can be directed will accelerate the development of treatments for brain damage, specifically from strokes and trauma.
"What we are hoping is that by manipulating this particular family of proteins we can encourage the stem cells to show a higher percentage of neural markers indicating that they could mature into neural cells rather than what they would normally do, which is form into bone, cartilage and fat," she said. She goes on to say, “The idea, for example, is that in stroke patients where the patient loses movement, speech or control of one side of their face because the brain's electrical current is impaired, that these stem cells will be able to be introduced and help the electrical current reconnect by bypassing the damaged cells."
QUT’s genomics research is an example of both the plasticity of MSCs and the potential for regenerative stem cell therapies to effectively treat seemingly intractable, historically incurable conditions. To learn more about stem cells and how to insure immediate access to emerging personalized regenerative treatments by banking your own valuable dental pulp stem cells, please visit StemSave or call 877-783-6728 (877- StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.